FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014180706> ?p ?o ?g. }

• W2014180706 endingPage "E1576" @default.
• W2014180706 startingPage "E1568" @default.
• W2014180706 abstract "Abstract Context: Dyslipidemia increases the risk of cardiovascular disease in obesity. Peroxisome proliferator-activated receptor (PPAR)-δ agonists decrease plasma triglycerides and increase high-density lipoprotein (HDL)-cholesterol in humans. Objective: The aim of the study was to examine the effect of GW501516, a PPAR-δ agonist, on lipoprotein metabolism. Design, Setting, and Intervention: We conducted a randomized, double-blind, crossover trial of 6-wk intervention periods with placebo or GW501516 (2.5 mg/d), with 2-wk placebo washout between treatment periods. Participants: We recruited 13 dyslipidemic men with central obesity from the general community. Main Outcome Measures: We measured the kinetics of very low-density lipoprotein (VLDL)-, intermediate-density lipoprotein-, and low-density lipoprotein (LDL)-apolipoprotein (apo) B-100, plasma apoC-III, and high-density lipoprotein (HDL) particles (LpA-I and LpA-I:A-II). Results: GW501516 decreased plasma triglycerides, fatty acid, apoB-100, and apoB-48 concentrations. GW501516 decreased the concentrations of VLDL-apoB by increasing its fractional catabolism and of apoC-III by decreasing its production rate (P &lt; 0.05). GW501516 reduced VLDL-to-LDL conversion and LDL-apoB production. GW501516 increased HDL-cholesterol, apoA-II, and LpA-I:A-II concentrations by increasing apoA-II and LpA-I:A-II production (P &lt; 0.05). GW501516 decreased cholesteryl ester transfer protein activity, and this was paralleled by falls in the triglyceride content of VLDL, LDL, and HDL and the cholesterol content of VLDL and LDL. Conclusions: GW501516 increased the hepatic removal of VLDL particles, which might have resulted from decreased apoC-III concentration. GW501516 increased apoA-II production, resulting in an increased concentration of LpA-I:A-II particles. This study elucidates the mechanism of action of this PPAR-δ agonist on lipoprotein metabolism and supports its potential use in treating dyslipidemia in obesity." @default.
• W2014180706 created "2016-06-24" @default.
• W2014180706 creator A5008118241 @default.
• W2014180706 creator A5055281543 @default.
• W2014180706 creator A5073109157 @default.
• W2014180706 creator A5075570233 @default.
• W2014180706 creator A5079564889 @default.
• W2014180706 date "2011-10-01" @default.
• W2014180706 modified "2023-10-16" @default.
• W2014180706 title "Mechanism of Action of a Peroxisome Proliferator-Activated Receptor (PPAR)-δ Agonist on Lipoprotein Metabolism in Dyslipidemic Subjects with Central Obesity" @default.
• W2014180706 cites W1502098572 @default.
• W2014180706 cites W1775749144 @default.
• W2014180706 cites W1968196140 @default.
• W2014180706 cites W1982027543 @default.
• W2014180706 cites W1984878434 @default.
• W2014180706 cites W1991325639 @default.
• W2014180706 cites W1996885736 @default.
• W2014180706 cites W1997090264 @default.
• W2014180706 cites W2007342896 @default.
• W2014180706 cites W2010542621 @default.
• W2014180706 cites W2011051352 @default.
• W2014180706 cites W2021976026 @default.
• W2014180706 cites W2031581250 @default.
• W2014180706 cites W2047589448 @default.
• W2014180706 cites W2049360498 @default.
• W2014180706 cites W2052300367 @default.
• W2014180706 cites W2077760013 @default.
• W2014180706 cites W2079434154 @default.
• W2014180706 cites W2099054337 @default.
• W2014180706 cites W2103409157 @default.
• W2014180706 cites W2111774300 @default.
• W2014180706 cites W2114808162 @default.
• W2014180706 cites W2117495354 @default.
• W2014180706 cites W2130702577 @default.
• W2014180706 cites W2133439372 @default.
• W2014180706 cites W2133834964 @default.
• W2014180706 cites W2140424137 @default.
• W2014180706 cites W2146788074 @default.
• W2014180706 cites W2150436995 @default.
• W2014180706 cites W2151251570 @default.
• W2014180706 cites W2158795285 @default.
• W2014180706 cites W2162261906 @default.
• W2014180706 cites W2164079954 @default.
• W2014180706 cites W2167817576 @default.
• W2014180706 cites W2169582126 @default.
• W2014180706 cites W2169911638 @default.
• W2014180706 cites W2170075604 @default.
• W2014180706 cites W4240713780 @default.
• W2014180706 doi "https://doi.org/10.1210/jc.2011-1131" @default.
• W2014180706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21816786" @default.
• W2014180706 hasPublicationYear "2011" @default.
• W2014180706 type Work @default.
• W2014180706 sameAs 2014180706 @default.
• W2014180706 citedByCount "71" @default.
• W2014180706 countsByYear W20141807062012 @default.
• W2014180706 countsByYear W20141807062013 @default.
• W2014180706 countsByYear W20141807062014 @default.
• W2014180706 countsByYear W20141807062015 @default.
• W2014180706 countsByYear W20141807062016 @default.
• W2014180706 countsByYear W20141807062017 @default.
• W2014180706 countsByYear W20141807062018 @default.
• W2014180706 countsByYear W20141807062019 @default.
• W2014180706 countsByYear W20141807062020 @default.
• W2014180706 countsByYear W20141807062021 @default.
• W2014180706 countsByYear W20141807062022 @default.
• W2014180706 countsByYear W20141807062023 @default.
• W2014180706 crossrefType "journal-article" @default.
• W2014180706 hasAuthorship W2014180706A5008118241 @default.
• W2014180706 hasAuthorship W2014180706A5055281543 @default.
• W2014180706 hasAuthorship W2014180706A5073109157 @default.
• W2014180706 hasAuthorship W2014180706A5075570233 @default.
• W2014180706 hasAuthorship W2014180706A5079564889 @default.
• W2014180706 hasBestOaLocation W20141807061 @default.
• W2014180706 hasConcept C126322002 @default.
• W2014180706 hasConcept C134018914 @default.
• W2014180706 hasConcept C185592680 @default.
• W2014180706 hasConcept C2778163477 @default.
• W2014180706 hasConcept C2780072125 @default.
• W2014180706 hasConcept C62746215 @default.
• W2014180706 hasConcept C71924100 @default.
• W2014180706 hasConcept C8243546 @default.
• W2014180706 hasConcept C86803240 @default.
• W2014180706 hasConceptScore W2014180706C126322002 @default.
• W2014180706 hasConceptScore W2014180706C134018914 @default.
• W2014180706 hasConceptScore W2014180706C185592680 @default.
• W2014180706 hasConceptScore W2014180706C2778163477 @default.
• W2014180706 hasConceptScore W2014180706C2780072125 @default.
• W2014180706 hasConceptScore W2014180706C62746215 @default.
• W2014180706 hasConceptScore W2014180706C71924100 @default.
• W2014180706 hasConceptScore W2014180706C8243546 @default.
• W2014180706 hasConceptScore W2014180706C86803240 @default.
• W2014180706 hasIssue "10" @default.
• W2014180706 hasLocation W20141807061 @default.
• W2014180706 hasLocation W20141807062 @default.
• W2014180706 hasOpenAccess W2014180706 @default.
• W2014180706 hasPrimaryLocation W20141807061 @default.
• W2014180706 hasRelatedWork W1998026951 @default.
• W2014180706 hasRelatedWork W1999568358 @default.

• next